Literature DB >> 9236691

Severe hypercalcaemia syndrome with daily low-dose vitamin D supplementation.

T L Jansen, M Janssen, A J de Jong.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236691     DOI: 10.1093/rheumatology/36.6.712

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


× No keyword cloud information.
  6 in total

1.  The authors respond to "Misconception about the cause of vitamin D toxicity".

Authors:  Bourne L Auguste; Joanne Bargman
Journal:  CMAJ       Date:  2019-07-08       Impact factor: 8.262

2.  Reply: Hypercalcaemia rather than high dose vitamin D3 supplements could exacerbate multiple sclerosis.

Authors:  Darius Häusler; Sebastian Torke; Evelyn Peelen; Thomas Bertsch; Marija Djukic; Roland Nau; Catherine Larochelle; Scott S Zamvil; Wolfgang Brück; Martin S Weber
Journal:  Brain       Date:  2019-12-01       Impact factor: 13.501

3.  Vitamin d toxicity in adults: a case series from an area with endemic hypovitaminosis d.

Authors:  Parvaiz A Koul; Sheikh Hilal Ahmad; Feroze Ahmad; Rafi A Jan; S U Shah; Umar H Khan
Journal:  Oman Med J       Date:  2011-05

4.  High dose vitamin D exacerbates central nervous system autoimmunity by raising T-cell excitatory calcium.

Authors:  Darius Häusler; Sebastian Torke; Evelyn Peelen; Thomas Bertsch; Marija Djukic; Roland Nau; Catherine Larochelle; Scott S Zamvil; Wolfgang Brück; Martin S Weber
Journal:  Brain       Date:  2019-09-01       Impact factor: 13.501

Review 5.  Benefit-risk assessment of vitamin D supplementation.

Authors:  H A Bischoff-Ferrari; A Shao; B Dawson-Hughes; J Hathcock; E Giovannucci; W C Willett
Journal:  Osteoporos Int       Date:  2009-12-03       Impact factor: 4.507

Review 6.  High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating Disease.

Authors:  Darius Häusler; Sebastian Torke; Martin S Weber
Journal:  Front Immunol       Date:  2020-02-25       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.